These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 24555957)

  • 21. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cephalosporin prices rising in wake of Pryor bill.
    Barlow RD
    Hosp Mater Manage; 1991 Jul; 16(7):1, 12-3. PubMed ID: 10112311
    [No Abstract]   [Full Text] [Related]  

  • 23. The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000-2009.
    Lichtenberg FR
    Econ Hum Biol; 2014 Mar; 13():107-27. PubMed ID: 23664114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical service pricing and pharmaceutical supply chain coordination contracts under the zero-markup drug policy.
    Zhou N; Li S; Zhao G; Li C; Yu N
    Front Public Health; 2023; 11():1208994. PubMed ID: 37927883
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmaceutical companies' variation of drug prices within and among countries can improve long-term social well-being.
    Lichtenberg FR
    Health Aff (Millwood); 2011 Aug; 30(8):1539-44. PubMed ID: 21821571
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Community drug expenditure and recent cost containment measures.
    Walshe V; Kenneally M
    Ir Med J; 2013 Feb; 106(2):44-6. PubMed ID: 23472384
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Attitudes of Slovene general practitioners towards generic drug prescribing and comparison with international studies.
    Kersnik J; Peklar J
    J Clin Pharm Ther; 2006 Dec; 31(6):577-83. PubMed ID: 17176362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The cost of the district hospital: a case study in Malawi.
    Mills AJ; Kapalamula J; Chisimbi S
    Bull World Health Organ; 1993; 71(3-4):329-39. PubMed ID: 8324852
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Medicines, medical care, manpower and mankind.
    Francke DE
    Am J Hosp Pharm; 1971 Jun; 28(6):410-21. PubMed ID: 5124723
    [No Abstract]   [Full Text] [Related]  

  • 30. Interhospital variations in hospital pharmacy markups.
    Johnston WP; Jacobs P; Dickson M
    Am J Hosp Pharm; 1985 Nov; 42(11):2492-5. PubMed ID: 3907337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Considerations in establishing fees for home-care pharmaceutical services.
    Mirtallo JM
    Am J Hosp Pharm; 1989 Jul; 46(7 Pt 2):S15-7. PubMed ID: 2672803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tackling corruption in the pharmaceutical systems worldwide with courage and conviction.
    Cohen JC; Mrazek M; Hawkins L
    Clin Pharmacol Ther; 2007 Mar; 81(3):445-9. PubMed ID: 17251983
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prices, availability and affordability of essential medicines in rural areas of Hubei Province, China.
    Yang H; Dib HH; Zhu M; Qi G; Zhang X
    Health Policy Plan; 2010 May; 25(3):219-29. PubMed ID: 19955093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Quality assurance in drug treatment by prescription drug analysis in a psychiatric treatment facility].
    Dumortier G; Van Nieuwenhuyse V; Zerrouk A; Chebili S; Glikman J; Degrassat K
    Encephale; 1999; 25(4):323-8. PubMed ID: 10546088
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Health insurance status, cost-related medication underuse, and outcomes among diabetes patients in three systems of care.
    Piette JD; Wagner TH; Potter MB; Schillinger D
    Med Care; 2004 Feb; 42(2):102-9. PubMed ID: 14734946
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A simulation model to evaluate pharmaceutical supply chain costs in hospitals: the case of a Colombian hospital.
    Franco C
    Daru; 2020 Jun; 28(1):1-12. PubMed ID: 30565158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Agent-Based Modeling and Simulation (ABMS)on the influence of adjusting medical service fees on patients' choice of medical treatment.
    Li D; Yang J; Li J; Zhao N; Ju W; Guo M
    BMC Health Serv Res; 2023 Aug; 23(1):928. PubMed ID: 37649036
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling drug costs.
    Jacobson SB
    Am J Public Health; 1972 Nov; 62(11):1441-2. PubMed ID: 5085505
    [No Abstract]   [Full Text] [Related]  

  • 39. Physicians' appreciation of drug charges to the patient.
    Kaine RF; O'Connell EJ
    Clin Pediatr (Phila); 1972 Dec; 11(12):665-6. PubMed ID: 4639309
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacy Expenditures for Children With Serious Chronic Illness.
    Ruble JH; Brixner DI
    JAMA; 2016 Feb; 315(7):706. PubMed ID: 26881378
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.